Approach to the Patient: Low Testosterone Concentrations in Men With Obesity - Takeaways - MDSpire

Approach to the Patient: Low Testosterone Concentrations in Men With Obesity

  • By

  • Christopher A Muir

  • Gary A Wittert

  • David J Handelsman

  • March 7, 2025

  • 0 min

Share

  • 1

    Pathologic hypogonadism requires lifelong testosterone replacement, while obesity-related low testosterone is often reversible with weight loss.

  • 2

    Obesity can cause pseudo-hypogonadism, characterized by low testosterone and normal LH and FSH, indicating a eugonadal state.

  • 3

    Testosterone treatment is not justified for men with obesity-related pseudo-hypogonadism, as lifestyle interventions are more effective.

  • 4

    There is no evidence that obesity causes pathological hypogonadism; the relationship is primarily due to obesity's impact on testosterone levels.

  • 5

    The misuse of testosterone therapy has increased significantly, despite a lack of approved indications for treating obesity-related low testosterone.

Original Source(s)

Approach to the Patient: Low Testosterone Concentrations in Men With Obesity

  • by Christopher A Muir, Gary A Wittert, David J Handelsman

  • March 7, 2025

Related Content

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Reorienting catch-up growth research toward early-life prevention of metabolic disorders using natural products

IPS Could Minimize GI Effects in Treating Iron Deficiency

Review summarizes pharmacokinetic and clinical data on iron protein succinylate across patients with iron deficiency and iron deficiency anemia.